Literature DB >> 16301676

Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.

Allan Tsung1, Rosemary A Hoffman, Kunihiko Izuishi, Nathan D Critchlow, Atsunori Nakao, Meagan H Chan, Michael T Lotze, David A Geller, Timothy R Billiar.   

Abstract

Endogenous ligands from damaged cells, so-called damage-associated molecular pattern molecules, can activate innate immunity via TLR4 signaling. Hepatic warm ischemia and reperfusion (I/R) injury and inflammation is largely TLR4 dependent. We produced TLR4 chimeric mice to assess whether the TLR4-dependent injury required TLR4 expression on liver parenchymal or nonparenchymal cells. Chimeric mice were produced by adoptive transfer of donor bone marrow cells into irradiated recipient animals using reciprocal combinations of TLR4 wild-type (WT; C3H/HeOuj) and TLR4 mutant (C3H/HeJ) mouse bone marrow. Wild-type chimeric mice bearing TLR4 mutant hemopoietic cells and TLR4 mutant mice transplanted with their own bone marrow-derived cells were protected from hepatic I/R and exhibited decreased JNK and NF-kappaB activation compared with WT chimeric mice transplanted with their own bone marrow. In contrast, TLR4 mutant mice transplanted with TLR4 WT bone marrow were not protected from liver I/R and demonstrated pronounced increases in JNK and NF-kappaB activation when compared with autochthonous transplanted mutant mice. In addition, depletion of phagocytes taking up gadolinium chloride failed to provide any additional protection to TLR4 mutant mice, but substantially reduced damage in WT mice after hepatic I/R. Together, these results demonstrate that TLR4 engagement on actively phagocytic nonparenchymal cells such as Kupffer cells is required for warm I/R-induced injury and inflammation in the liver.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301676     DOI: 10.4049/jimmunol.175.11.7661

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  147 in total

1.  Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.

Authors:  Jan Petrasek; Angela Dolganiuc; Timea Csak; Bharath Nath; Istvan Hritz; Karen Kodys; Donna Catalano; Evelyn Kurt-Jones; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

2.  Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Authors:  Jamie C Zampell; Sonia Elhadad; Tomer Avraham; Evan Weitman; Seth Aschen; Alan Yan; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

Review 3.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

4.  Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Ritha M Belizaire; Ralph Cutler Quillin; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  J Gastroenterol Hepatol       Date:  2012-10       Impact factor: 4.029

5.  NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.

Authors:  Chia-Lin Chen; Dinesh Babu Uthaya Kumar; Vasu Punj; Jun Xu; Linda Sher; Stanley M Tahara; Sonja Hess; Keigo Machida
Journal:  Cell Metab       Date:  2015-12-24       Impact factor: 27.287

6.  Differential toll-like receptor activation in lung ischemia reperfusion injury.

Authors:  Patrick Phelan; Heather E Merry; Billanna Hwang; Michael S Mulligan
Journal:  J Thorac Cardiovasc Surg       Date:  2015-02-28       Impact factor: 5.209

7.  TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation.

Authors:  Stavros Garantziotis; Zhuowei Li; Erin N Potts; James Y Lindsey; Vandy P Stober; Vasiliy V Polosukhin; Timothy S Blackwell; David A Schwartz; W Michael Foster; John W Hollingsworth
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

Review 8.  Ischaemia-reperfusion injury in liver transplantation--from bench to bedside.

Authors:  Yuan Zhai; Henrik Petrowsky; Johnny C Hong; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-12-11       Impact factor: 46.802

9.  Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury.

Authors:  Zubin M Bamboat; Vinod P Balachandran; Lee M Ocuin; Hebroon Obaid; George Plitas; Ronald P DeMatteo
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 10.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.